Infectious Disease Point-of-Care Diagnostics: Fast and Accurate Testing at the Bedside
Based on Fortune Business Insights’ report, the infectious disease point-of-care diagnostics Market share sector attained a worth of USD 15.81 Billion in 2022. Forecasts indicate a promising path ahead, foreseeing a Compound Annual Growth Rate (CAGR) of -2.8% from 2022 to 2030. This trajectory will culminate in a noteworthy achievement of USD 12.46 Billion by 2030, highlighting considerable opportunities within this flourishing high-volume industry. North America dominated the market in 2022.
Request a Free Sample PDF Brochure of Infectious Disease Point-of-care Diagnostics Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/104307
In a recent study, Fortune Business Insights presents the nitty-gritty of the global Infectious Disease Point-of-care Diagnostics Market considering 2024–2032 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities, and trends affecting market growth. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.
Top companies in the Infectious Disease Point-of-care Diagnostics Market:
- F. Hoffmann-La Roche Ltd(Basel, Switzerland)
- Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
- Abbott Laboratories (Illinois, U.S)
- Quest Diagnostics Incorporated (New Jersey, United States)
- BD (Franklin Lakes, U.S)
- bioMrieux SA (Marcy l’Etoile, France)
- Cardinal Health, Inc.(Ohio, U.S)
- Mesa Biotech (California, U.S)
- Cepheid (California, U.S)
- Trinity Biotech (Bray, Ireland)
- Quidel Corporation (San Diego, U.S.)
- Bio-Rad Laboratories Inc. (California, U.S)
- Other Players
The Infectious Disease Point-of-care Diagnostics Market study outlines the key regions of North America, Latin America, Europe, East Asia, and Japan along with the countries contributing the most in the respective regions. The report presents detailed insights about each market player, including SWOT analysis, main market information, market share, revenue, pricing, and gross margin.
Infectious Disease Point-of-care Diagnostics Market Dynamics:
- Increasing prevalence of infectious diseases
- Rising demand for rapid and accurate diagnostic tests
- Advancements in technology and product innovation
- Growing awareness and adoption of point-of-care diagnostics
- Government initiatives and funding for healthcare infrastructure
Speak to Analyst for Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/104307
The insights for each vendor consist of:
- Company profile
- SWOT analysis
- Main market information
- Market share
- Revenue, pricing, and gross margin
Crucial insights in the Infectious Disease Point-of-care Diagnostics Market research:
- Underlying macro- and microeconomic factors impacting the growth of the Infectious Disease Point-of-care Diagnostics Market.
- Basic overview of Infectious Disease Point-of-care Diagnostics Market, including market definition, classification, and applications.
- Scrutinization of each Infectious Disease Point-of-care Diagnostics Market player based on mergers & acquisitions, R&D projects, and product launches.
- Adoption trend of Infectious Disease Point-of-care Diagnostics Market across various industries.
- Important regions and countries offer lucrative opportunities to Infectious Disease Point-of-care Diagnostics Market stakeholders.
Important regions covered in the Infectious Disease Point-of-care Diagnostics Market report include:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Table of Contents:
- Introduction
- Research Scope
- Customer Segmentation
- Data Gathering Strategies
- Key Definitions & Caveats
- Executive Summary
- Market Dynamics
- Infectious Disease Point-of-care Diagnostics Market Drivers
- Infectious Disease Point-of-care Diagnostics Market Restraints
- Market Opportunities
- Key Insights
- Value Chain
- Major M&A moves and game-changing partnerships.
- Covid-19 Impact
- Future of the Healthcare Industry
- Competitive Landscape
- Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
- Infectious Disease Point-of-care Diagnostics Market Growth Size 2024
- Strategies Adopted by Leading Players
- Company Profiles (Overview, Financials, Products and Services, and Recent Developments)
- Disclaimer
TOC Continued…!
Order a copy of this research report at: https://www.fortunebusinessinsights.com/checkout-page/104307
FAQ’s
- How big is the Infectious Disease Point-of-care Diagnostics Market?
- What factors are influencing the Infectious Disease Point-of-care Diagnostics Market growth in North America?
- Who are the key Infectious Disease Point-of-care Diagnostics Market players?
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies interspersed with relevant data.
At Fortune Business Insights, we aim to highlight our clients’ most lucrative growth opportunities. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA:+1 424 253 0390,
United Kingdom: +44 2071 939123,
APAC: +91 744 740 1245